s 9788 has been researched along with technetium tc 99m sestamibi in 2 studies
Studies (s 9788) | Trials (s 9788) | Recent Studies (post-2010) (s 9788) | Studies (technetium tc 99m sestamibi) | Trials (technetium tc 99m sestamibi) | Recent Studies (post-2010) (technetium tc 99m sestamibi) |
---|---|---|---|---|---|
49 | 4 | 0 | 5,774 | 627 | 1,208 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cayre, A; Finat-Duclos, F; Maublant, J; Moins, N; Verrelle, P | 2 |
2 other study(ies) available for s 9788 and technetium tc 99m sestamibi
Article | Year |
---|---|
Comparison between technetium-99m-sestamibi and hydrogen-3-daunomycin myocardial cellular retention in vitro.
Topics: Animals; Animals, Newborn; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cells, Cultured; Cyclosporins; Daunorubicin; Drug Resistance, Neoplasm; Genes, MDR; Heart; In Vitro Techniques; Myocardium; Piperidines; Radionuclide Imaging; Rats; Rats, Wistar; Technetium Tc 99m Sestamibi; Triazines; Tritium; Verapamil | 1997 |
Comparative 99mTc-sestamibi and 3H-daunomycin uptake in human carcinoma cells: relation to the MDR phenotype and effects of reversing agents.
Topics: Antibiotics, Antineoplastic; Antineoplastic Agents; Cyclosporins; Daunorubicin; Drug Resistance, Multiple; Humans; Piperidines; Radiopharmaceuticals; Reverse Transcriptase Polymerase Chain Reaction; Technetium Tc 99m Sestamibi; Triazines; Tritium; Tumor Cells, Cultured; Verapamil | 1999 |